Loxo Oncology Balance Sheet - Annual (NASDAQ:LOXO)

Add to My Stocks
$157.59 $2.13 (1.37%) LOXO stock closing price Sep 18, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Loxo Oncology stock analysis. Financial strength can be guaged by performing Loxo Oncology stock analysis and by analyzing the balance sheet. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. The Loxo Oncology balance sheet for 2017 shows total assets of $783.44M. The company has a asset turnover ratio of . Also see: Loxo Oncology revenue and Loxo Oncology operating cash flow for the same year.

View latest 10 year balance sheet data to check Loxo Oncology financial performance.
show more
Fiscal year is Jan - Dec20172016201520142013
Cash142.02M30.37M68.17M43.93M14.99M
Marketable Securities484.17M108.93M85.71M62.36M-
Receivables150M----
Inventory-----
Raw Materials-----
Work In Progress-----
Finished Goods-----
Notes Receivable-----
Other Current Assets5.6M2.48M2.75M1.48M-
Total Current Assets
781.8M141.79M156.64M107.77M15.01M
Property Plant & Equipment-----
Accumulated Depreciation-----
Net Property Plant & Equipment
-----
Investment & Advances-2.49M-6.64M-
Other Non-Current Assets-----
Deferred Charges-----
Intangibles-----
Deposits & Other Assets-----
Total Assets
783.44M145.31M157.45M114.45M15.02M
Notes Payable-----
Accounts Payable3.99M1.06M---
Current Portion Long-Term Debt-----
Current Portion Capital Leases-----
Accrued Expenses22.53M14.08M2.58M1.54M-
Income Taxes Payable-----
Other Current Liabilities195.03M----
Total Current Liabilities
221.57M15.14M2.85M1.78M-
Mortgages-----
Deferred Taxes/Income183.66M----
Convertible Debt-----
Long-Term Debt-----
Non-Current Capital Leases-----
Other Long-Term Liabilities-----
Total Liabilities
405.23M15.14M2.85M1.78M-
Minority Interest-----
Preferred Stock----24.84M
Common Stock Net-----
Capital Surplus666.89M269.42M221.45M143.66M-
Retained Earnings-288.11M-139.23M-66.83M-30.96M-10.29M
Treasury Stock-----
Other Liabilities-0.57M-0.02M-0.01M-0.02M-
Shareholders Equity378.21M130.16M154.6M112.67M14.61M
Total Liabilities & Shareholders Equity783.44M145.31M157.45M114.45M15.02M
All figures in USD. M: Millions of USD, B: Billions of USD.

Looking at Loxo Oncology historical stock prices and the current Loxo Oncology stock price can tell you how the stock price has moved, whereas the Loxo Oncology PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: An asset is a resource that a corporation like Loxo Oncology owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for LOXO stock as of 2017 is $783.44M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: The total liabilities of Loxo Oncology for the year 2017 total to $405.23M. Liabilities for a company like Loxo Oncology include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Loxo Oncology Balance Sheet - Key Ratios